Citigroup Inc Pds Biotechnology Corp Transaction History
Citigroup Inc
- $169 Billion
- Q3 2024
A detailed history of Citigroup Inc transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Citigroup Inc holds 22 shares of PDSB stock, worth $39. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22
Previous 23,503
99.91%
Holding current value
$39
Previous $68,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PDSB
# of Institutions
64Shares Held
4.32MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.52MShares$2.74 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$876,5400.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$747,2030.0% of portfolio
-
Inspirion Wealth Advisors, LLC344KShares$619,9090.18% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$421,5760.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $51.2M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...